{
  "meta": {
    "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.",
    "terms": "https://open.fda.gov/terms/",
    "license": "https://open.fda.gov/license/",
    "last_updated": "2026-07-01",
    "results": {
      "skip": 0,
      "limit": 1,
      "total": 1
    }
  },
  "results": [
    {
      "country": "United States",
      "city": "Vancouver",
      "address_1": "14301 Se 1st St",
      "reason_for_recall": "Labeling: Label Mixup; ORPHENADRINE CITRATE ER Tablet, 100 mg may be potentially mislabeled as    OMEGA-3 FATTY ACID, Capsule, 1000 mg, NDC 40985022921, Pedigree: W002965, EXP: 6/10/2014.",
      "address_2": "",
      "product_quantity": "100 Tablets",
      "code_info": "ORPHENADRINE CITRATE ER, Tablet, 100 mg has the folowing code    Pedigree: W002962, EXP: 6/11/2014.",
      "center_classification_date": "20140116",
      "distribution_pattern": "Repacked drugs were distributed in Arizona, California, Oregon, and Washington.",
      "state": "WA",
      "product_description": "ORPHENADRINE CITRATE ER Tablet, 100 mg, Rx only, Distributed by: AidaPak Service, LLC, NDC 43386048024",
      "report_date": "20140122",
      "classification": "Class II",
      "openfda": {},
      "recalling_firm": "Aidapak Services, LLC",
      "recall_number": "D-566-2014",
      "initial_firm_notification": "Telephone",
      "product_type": "Drugs",
      "event_id": "65707",
      "termination_date": "20140207",
      "more_code_info": "",
      "recall_initiation_date": "20130702",
      "postal_code": "98684-3501",
      "voluntary_mandated": "Voluntary: Firm initiated",
      "status": "Terminated"
    }
  ]
}